COMMUNIQUÉS West-GlobeNewswire

IntelGenx Provides Update on Phase 2a Montelukast VersaFilm™ Clinical Trial

23/01/2019 - 14:00

Eight Alzheimer’s Disease Patients Randomized to Date with Two Additional Sites Expected SAINT LAURENT, Quebec, Jan. 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral [...]

Cabaletta Bio Appoints Anup Marda as Chief Financial Officer

23/01/2019 - 14:00

Mr. Marda joins Cabaletta with 17 years of financial leadership experience RADNOR, Pa., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a biotechnology company focused on the discovery and development of cellular [...]

Telix Pharmaceuticals Launches illumet™ Microsite (Kit for the Preparation of 68Ga-PSMA)

23/01/2019 - 14:00

MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and [...]

BioCorRx Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market

23/01/2019 - 14:00

ANAHEIM, CA, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX; BICXD) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, [...]

InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard™ EPS at the Leipzig Interventional Course (LINC) 2019

23/01/2019 - 14:00

Cases demonstrate ease-of-use of CGuard™ EPS in two challenging clinical situations physicians face when treating carotid artery disease TEL AVIV, Israel, Jan. 23, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American [...]

ProMIS Neurosciences Completes Private Placement of Units

23/01/2019 - 13:30

NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (“ ProMIS ” or the “ Company ”) (TSX: PMN); (OTCQB:ARFXF) is [...]

T2 Biosystems to Participate in Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

23/01/2019 - 13:00

Company to highlight groundbreaking diagnostic innovations impacting antimicrobial resistance and sepsis management LEXINGTON, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the [...]

Sharps Compliance Reports Fiscal 2019 Second Quarter Results

23/01/2019 - 12:45

Second quarter 2019 revenue increased to $12.4 million with gross margin of 32%, net income of $0.8 million and $0.05 earnings per share Mailback business increased 20% for the quarter reflecting strong flu business [...]

Publishing of Orion Corporation's Financial Statement Release for 2018 on 6 February 2019

23/01/2019 - 12:31

ORION CORPORATION PRESS RELEASE 23 JANUARY 2019 at 13.30 EET Publishing of Orion Corporation's Financial Statement Release for 2018 on 6 February 2019 Orion will publish its Financial Statement Release for 2018 on [...]

New Study Shows Supplementation with Nicotinamide Riboside (NR) During Breastfeeding Yields Measurable, Lasting Benefits to Mothers and Offspring in Animal Model

23/01/2019 - 12:30

Landmark preclinical lactation study of unique form of vitamin B3 (nicotinamide riboside) showing remarkable results in rodents published in Cell Reports LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. ( [...]

Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem® Cell Therapy for Treatment of Acute Respiratory Distress Syndrome (ARDS)

23/01/2019 - 12:00

Results Confirm Safety Profile and Demonstrate Meaningful Potential Benefits in Mortality, Ventilator-free Days and ICU-free Days CLEVELAND, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced [...]

New REDUCE-IT™ Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American College of Cardiology’s 68th Annual Scientific Session

23/01/2019 - 12:00

BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced that new data showing the [...]

Bellerophon Announces Pricing of $7 Million Public Offering of Common Stock

23/01/2019 - 12:00

WARREN, N.J., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced the pricing of an underwritten [...]

CORRECTION: Aino Health AB (publ): Smart Health Management brought big rewards for Tornio

23/01/2019 - 11:16

This is a correction of the announcement from 08:30 23.01.2019 CET. Reason for the correction: January 23 2019 The municipality of Tornio is a forerunner in the strategic utilization of health management. The work, [...]

Update: ObsEva SA Reports Initial Good Safety of OBE022 in Pregnant Women with Preterm Labour and Announces Start of Part B of the PROLONG Trial

23/01/2019 - 09:28

Geneva, Switzerland and Boston, MA – January 23, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]

Aino Health AB (publ): Smart Health Management brought big rewards for Tornio

23/01/2019 - 08:31

January 23 2019 The municipality of Tornio is a forerunner in the strategic utilization of health management. The work, started ten years ago, has yielded solid results. Anja Huhtanen, HR Manager for Tornio, says that [...]

Saniona reports UPenn to continue cocaine addiction study with NS2359 at higher dose after blinded interim analysis

23/01/2019 - 08:00

PRESS RELEASE January 23, 2019 University of Pennsylvania Treatment Research Center continues investigator-initiated study Decision based on interim analysis of blinded data for first 50 patients Good scientific [...]

ASLAN Announces Publication of New Pre-Clinical Data Demonstrating the Activity of Varlitinib in TNBC Cell Lines

23/01/2019 - 07:35

SINGAPORE, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]

ObsEva SA Reports Initial Good Safety of OBE022 in Pregnant Women with Preterm Labour and Announces Start of Part B of the PROLONG Trial

23/01/2019 - 07:00

Geneva, Switzerland and Boston, MA – January 23, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]